Inhibition of DEPDC1A, a bad prognostic marker in multiple myeloma, delays growth and induces mature plasma cell markers in malignant plasma cells.
High throughput DNA microarray has made it possible to outline genes whose expression in malignant plasma cells is associated with short overall survival of patients with Multiple Myeloma (MM). A further step is to elucidate the mechanisms encoded by these genes yielding to drug resistance and/or pa...
Guardado en:
Autores principales: | Alboukadel Kassambara, Matthieu Schoenhals, Jérôme Moreaux, Jean-Luc Veyrune, Thierry Rème, Hartmut Goldschmidt, Dirk Hose, Bernard Klein |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/508612106bfa427fa972fa82872ef90a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Identification of pluripotent and adult stem cell genes unrelated to cell cycle and associated with poor prognosis in multiple myeloma.
por: Alboukadel Kassambara, et al.
Publicado: (2012) -
The glycome of normal and malignant plasma cells.
por: Thomas M Moehler, et al.
Publicado: (2013) -
Primary plasma cell leukemia: consensus definition by the International Myeloma Working Group according to peripheral blood plasma cell percentage
por: Carlos Fernández de Larrea, et al.
Publicado: (2021) -
Molecular markers of susceptibility to ocular toxoplasmosis, host and guest behaving badly
por: Adriana Lima Vallochi, et al.
Publicado: (2008) -
A SCREENING RESEARCH OF PLASMA BLOOD DONORS FOR MARKERS PARVOVIRUS INFECTION
por: Anastassia Ya. Antipova, et al.
Publicado: (2015)